Pfizer raises 2021 Covid-19 vaccine sales forecast to $33.5 billion
ঢাকা ট্রিবিউন
প্রকাশিত: ২৮ জুলাই ২০২১, ১৭:৩৪
Pfizer gained a head start in December with the first US emergency authorization of a Covid-19 vaccine, and has since jumped ahead of rivals that have faced manufacturing hurdles
